首页> 外文期刊>Hepato-gastroenterology. >Decreased Expression of SOX9 in Intraductal Papillary Mucinous Neoplasms of the Bile Duct
【24h】

Decreased Expression of SOX9 in Intraductal Papillary Mucinous Neoplasms of the Bile Duct

机译:SOX9在胆管导管内乳头状黏液性肿瘤中的表达降低

获取原文
获取原文并翻译 | 示例
       

摘要

Background/Aims: SOX9 is an important transcription factor required for development and has been implicated in several types of malignant tumor. Our recent study showed that SOX9 played an important role in multi-step carcinogenesis in cases of intraductal papillary mucinous tumor of the pancreas (IPMN-P). This study aimed to investigate the expression of SOX9 in cases of intraductal papillary mucinous tumor of the bile duct (IPMN-B). Methodology: SOX9 expression was immunohistochemically evaluated in the tumor and corresponding normal bile-duct epithelium of seven IPMN-B patients. Results: In all cases, SOX9 expression in the IPMN-B was low compared with the normal biliary epithelium. Conclusions: This study demonstrated that SOX9 expression may indicate a link between IPMN-B and IPMN-P. SOX9 may also have potential as a therapeutic target and/or prognostic marker in IPMN-B.
机译:背景/目的:SOX9是发育所需的重要转录因子,已与多种类型的恶性肿瘤有关。我们最近的研究表明,在胰腺导管内乳头状粘液性肿瘤(IPMN-P)的病例中,SOX9在多步癌变中起着重要作用。本研究旨在探讨SOX9在胆管内乳头状黏液性肿瘤(IPMN-B)中的表达。方法:对7例IPMN-B患者的肿瘤和相应的正常胆管上皮进行了SOX9表达的免疫组织化学评估。结果:在所有情况下,IPMN-B中的SOX9表达均低于正常胆道上皮。结论:这项研究表明SOX9表达可能表明IPMN-B和IPMN-P之间存在联系。 SOX9也可能具有作为IPMN-B中的治疗靶标和/或预后标志物的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号